Literature DB >> 24311880

Erythrocyte membrane fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oils.

Soheila Rezapour-Firouzi1, Seyed Rafie Arefhosseini, Mehrangiz Ebrahimi-Mamaghani, Mehdi Farhoudi, Behzad Baradaran, Torbati Mohammad Ali, Fatemeh Zamani.   

Abstract

The risk of developing multiple sclerosis (MS) is associated with increased dietary intake of saturated fatty acids. For many years it has been suspected that this disease might be associated with an imbalance between unsaturated and saturated fatty acids. We determined erythrocyte membrane fatty acids levels in Hot nature dietary intervention with co-supplemented hemp seed and evening primrose oils in multiple sclerosis patients. To determine the erythrocyte membrane fatty acids levels and correlate it with expanded disability status scale (EDSS) at baseline after 6 months intervention in MS patients by gas chromatography, in this double blind, randomized trial, 100 RRMS patients with EDSS<6 were allocated into three groups: "Group A" that received co-supplemented hemp seed and evening primrose oils with advised Hot nature diet. "Group B" received olive oil and "Group C" received the co-supplemented oils. The results showed that the mean follow-up was 180 ± 2.9SD days (N=65, 23 M and 42 F aged 34.25 ± 8.07 years with disease duration of 6.80 ± 4.33 years). There was no significant difference in the study parameters at baseline. After 6 months, EDSS, Immunological parameters and the erythrocyte cell membrane with regard to specific fatty acids showed improvement in the group A and C, whereas there was worsening condition for the group B after the intervention. We concluded that Hot-nature dietary intervention with co-supplemented hemp seed and evening primrose oils caused an increase PUFAs in MS patients and improvement in the erythrocyte membrane fatty acids composition. This could be an indication of restored plasma stores, and a reflection of disease severity reduction.

Entities:  

Keywords:  Cannabis sativa L; Cell membrane fluidity (CMF); Oenothera biennis L; Polyunsaturated fatty acid; expanded disability status scale (EDSS)

Mesh:

Substances:

Year:  2013        PMID: 24311880      PMCID: PMC3847395          DOI: 10.4314/ajtcam.v10i6.22

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  47 in total

Review 1.  Antioxidants and polyunsaturated fatty acids in multiple sclerosis.

Authors:  M E van Meeteren; C E Teunissen; C D Dijkstra; E A F van Tol
Journal:  Eur J Clin Nutr       Date:  2005-12       Impact factor: 4.016

2.  Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada.

Authors:  P Ghadirian; M Jain; S Ducic; B Shatenstein; R Morisset
Journal:  Int J Epidemiol       Date:  1998-10       Impact factor: 7.196

Review 3.  Lipid peroxidation in mitochondrial membrane.

Authors:  Y A Vladimirov; V I Olenev; T B Suslova; Z P Cheremisina
Journal:  Adv Lipid Res       Date:  1980

4.  Membrane fluidity as an index of pathology.

Authors:  J A Scott
Journal:  Med Hypotheses       Date:  1982-08       Impact factor: 1.538

Review 5.  Multiple sclerosis and nutrition.

Authors:  Stefan Schwarz; Hans Leweling
Journal:  Mult Scler       Date:  2005-02       Impact factor: 6.312

6.  Isolation and characterization of subcellular membranes with altered phospholipid composition from cultured fibroblasts.

Authors:  F Schroeder; J F Perlmutter; M Glaser; P R Vagelos
Journal:  J Biol Chem       Date:  1976-08-25       Impact factor: 5.157

Review 7.  Lipids as targets for novel anti-inflammatory therapies.

Authors:  Andrea Huwiler; Josef Pfeilschifter
Journal:  Pharmacol Ther       Date:  2009-06-30       Impact factor: 12.310

8.  Nutrition, latitude, and multiple sclerosis mortality: an ecologic study.

Authors:  M L Esparza; S Sasaki; H Kesteloot
Journal:  Am J Epidemiol       Date:  1995-10-01       Impact factor: 4.897

9.  Red blood cell fatty acids in multiple sclerosis.

Authors:  X Navarro; R Segura
Journal:  Acta Neurol Scand       Date:  1989-01       Impact factor: 3.209

Review 10.  Neuropathology of multiple sclerosis-new concepts.

Authors:  Barbara Kornek; Hans Lassmann
Journal:  Brain Res Bull       Date:  2003-08-15       Impact factor: 4.077

View more
  5 in total

Review 1.  Influence of Diet in Multiple Sclerosis: A Systematic Review.

Authors:  M José Bagur; M Antonia Murcia; Antonia M Jiménez-Monreal; Josep A Tur; M Mar Bibiloni; Gonzalo L Alonso; Magdalena Martínez-Tomé
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

Review 2.  Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.

Authors:  Graziella Filippini; Silvia Minozzi; Francesca Borrelli; Michela Cinquini; Kerry Dwan
Journal:  Cochrane Database Syst Rev       Date:  2022-05-05

Review 3.  Efficacy and Tolerability of Phytomedicines in Multiple Sclerosis Patients: A Review.

Authors:  Mohammad Hosein Farzaei; Zahra Shahpiri; Roodabeh Bahramsoltani; Marjan Moghaddam Nia; Fariba Najafi; Roja Rahimi
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 6.497

4.  Dietary interventions for multiple sclerosis-related outcomes.

Authors:  Natalie E Parks; Caitlin S Jackson-Tarlton; Laura Vacchi; Roah Merdad; Bradley C Johnston
Journal:  Cochrane Database Syst Rev       Date:  2020-05-19

Review 5.  The Sources of Essential Fatty Acids for Allergic and Cancer Patients; a Connection with Insight into Mammalian Target of Rapamycin: A Narrative Review

Authors:  Zhila Arshad; Soheila Rezapour-Firouzi; Mahshid Mohammadian
Journal:  Asian Pac J Cancer Prev       Date:  2018-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.